ANGO in the 13F filings
Angiodynamics Inc · CUSIP 03475V101
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 15 May 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 19
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 2 listed it in both
- Shares listed
- 7,897,153
- combined, among listed positions
- Reported value
- $90m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 11 buyers (opened or added shares) and 13 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +251,619.
Managers listing ANGO in Q1 2026
19 of 19 holders
Largest increases and reductions, by shares
Increases
- Point72 Asset Management LPexisting position · 3,181,829 shares now+356,330
- Acadian Asset Management LLCexisting position · 468,670 shares now+278,393
- Marshall Wace LLPexisting position · 485,504 shares now+200,816
- Squarepoint Ops LLCexisting position · 93,787 shares now+52,684
- Tudor Investment Corpnew position · 46,314 shares now+46,314
Reductions
- Jane Street Group LLCexisting position · 101,934 shares now-198,966
- Millennium Management LLCexisting position · 644,677 shares now-197,871
- Two Sigma Investments LPexisting position · 230,451 shares now-74,409
- Susquehanna International Group LLPexisting position · 20,646 shares now-42,485
- Renaissance Technologies LLCexisting position · 803,283 shares now-39,800
New positions and exits
New (1)
Exited (5)
- Verition Fund Management LLCwas $999k
- ExodusPoint Capital Management LPwas $609k
- D. E. Shaw & Co.was $297k
- Brevan Howard Capital Management LPwas $164k
- Quantbot Technologies LPwas $6k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2016 | 1 | $971k | n.a. | n.a. |
| Q4 2016 | 1 | $9.0m | n.a. | n.a. |
| Q1 2017 | 1 | $6.7m | n.a. | n.a. |
| Q2 2017 | 3 | $9.0m | n.a. | n.a. |
| Q1 2018 | 1 | $12m | n.a. | n.a. |
| Q2 2018 | 2 | $18m | n.a. | n.a. |
| Q3 2018 | 2 | $8.1m | n.a. | n.a. |
| Q4 2018 | 1 | $5.7m | n.a. | n.a. |
| Q1 2019 | 1 | $5.2m | n.a. | n.a. |
| Q2 2019 | 2 | $4.7m | n.a. | n.a. |
| Q3 2019 | 1 | $5.2m | n.a. | n.a. |
| Q4 2019 | 1 | $5.7m | n.a. | n.a. |
| Q1 2020 | 1 | $4.8m | n.a. | n.a. |
| Q1 2021 | 1 | $10m | n.a. | n.a. |
| Q2 2021 | 1 | $19m | n.a. | n.a. |
| Q4 2021 | 1 | $21m | n.a. | n.a. |
| Q1 2022 | 1 | $25m | n.a. | n.a. |
| Q2 2022 | 1 | $18m | n.a. | n.a. |
| Q3 2022 | 1 | $13m | n.a. | n.a. |
| Q1 2023 | 1 | $388k | n.a. | n.a. |
| Q2 2023 | 1 | $391k | n.a. | n.a. |
| Q3 2023 | 1 | $6.0m | n.a. | n.a. |
| Q4 2023 | 3 | $13m | 2 | 1 |
| Q1 2024 | 1 | $5.9m | 1 | 0 |
| Q2 2024 | 2 | $7.5m | 2 | 0 |
| Q3 2024 | 1 | $3.1m | 1 | 0 |
| Q4 2024 | 1 | $3.8m | 1 | 0 |
| Q1 2025 | 2 | $4.4m | 1 | 1 |
| Q2 2025 | 2 | $3.9m | 1 | 1 |
| Q3 2025 | 3 | $34m | 2 | 1 |
| Q4 2025 | 2 | $5.6m | 16 | 9 |
| Q1 2026 | 2 | $5.4m | 11 | 13 |
| Q2 2026 | 2 | $6.0m | 11 | 11 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ANGO and LLY →ANGO and JNJ →ANGO and VRTX →Choose a stock to compare with ANGO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ANGO, latest filings →Back to the 13F Explorer →